| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.3 |